← ANALYST RATINGS · TIPRANKS
Cigna (CI): analyst forecast and price target
Analyst consensus
Moderate Buy9 Buy4 Hold0 Sell
Ratings of 13 analysts in the last 3 months · top analysts only12-month forecast
Based on 13 price targets given in the last 3 months, the average target is $338, the highest $387, the lowest $290. The average is +11.9% from the last price of $302.
Analyst ratings 23
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Healthcare PlansxAI Grok-4 | TipRanks - xAI | $317 → $348+9.8% | Buy | +15.1% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| AI DeepSeek Medical - Healthcare PlansDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $306 → $336+9.8% | Buy | +11.1% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| AI OpenAI Medical - Healthcare PlansOpenAI 5.2 | TipRanks - OpenAI | $310 → $340+9.7% | Buy | +12.5% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| AI Anthropic Medical - Healthcare PlansAnthropic Opus-4.6 | TipRanks - Anthropic | $295 → $323+9.5% | Hold | +6.8% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| AI Google Medical - Healthcare PlansGemini 3.1Pro | TipRanks - Google | $315 → $346+9.8% | Buy | +14.5% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| AI PerPlexity Medical - Healthcare PlansPerPlexity SonarPro | TipRanks - PerPlexity | $319 → $351+10.0% | Buy | +16.1% | Reiterated | 17.10.26on TipRanks 03:05 | — | |
| Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% | RBC Capital | $337 | Buy | +11.5% | Reiterated | 07.10.26on TipRanks Oct 8 21:45 | +1.7%next day +1.3% · 5 days +5.0% | ↗ |
| Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% | Bernstein | $381 → $387+1.6% | Buy | +28.0% | Reiterated | 05.10.26on TipRanks 07:30 | −0.4%next day +0.6% · 5 days +4.0% | ↗ |
| David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% | Truist Financial | $350 | Buy | +15.8% | Reiterated | 02.10.26on TipRanks 07:35 | +0.2%next day −0.4% · 5 days +3.2% | ↗ |
| Jessica Tassan★★★★★★★★★★#11189 · hits 43% · avg −3.3% | Piper Sandler | $346 → $370+6.9% | Buy | +22.4% | Reiterated | 02.10.26on TipRanks 06:55 | +0.2%next day −0.4% · 5 days +3.2% | ↗ |
| Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% | Evercore ISI | $290 | Hold | −4.1% | Reiterated | 01.10.26on TipRanks 09:25 | −1.6%next day +0.2% · 5 days +3.6% | ↗ |
| Unknown Analyst | Leerink Partners | $300 | Hold | −0.8% | Reiterated | 01.10.26on TipRanks 09:25 | −1.6%next day +0.2% · 5 days +3.6% | ↗ |
| Michael Wiederhorn★★★★★★★★★★#535 · hits 59% · avg +11.3% | Oppenheimer | $365 | Buy | +20.7% | Reiterated | 01.10.26on TipRanks 08:10 | −1.6%next day +0.2% · 5 days +3.6% | ↗ |
| Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% | Barclays | $310 | Hold | +2.5% | Reiterated | 01.10.26on TipRanks 05:15 | −1.6%next day +0.2% · 5 days +3.6% | ↗ |
| Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% | Bank of America Securities | $378 | Buy | +25.0% | Reiterated | 01.10.26on TipRanks 05:15 | −1.6%next day +0.2% · 5 days +3.6% | ↗ |
| Charles Rhyee★★★★★★★★★★#1937 · hits 54% · avg +5.6% | TD Cowen | $338 | Buy | +11.8% | Reiterated | 30.09.26on TipRanks Oct 1 07:21 | −1.0%next day −1.6% · 5 days +0.5% | ↗ |
| Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% | Wells Fargo | $307 | Hold | +1.6% | Reiterated | 30.09.26on TipRanks Oct 1 05:30 | −1.0%next day −1.6% · 5 days +0.5% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $361 | Buy | +19.4% | Reiterated | 29.09.26on TipRanks 07:15 | +1.4%next day −1.0% · 5 days −2.3% | ↗ |
| David Windley★★★★★★★★★★#769 · hits 59% · avg +9.3% | Jefferies | $336 → $307−8.6% | Hold | +1.6% | Downgrade | 03.08.26on TipRanks Aug 4 05:36 | −0.3%next day −4.6% · 5 days −3.3% | ↗ |
| Parker Snure★★★★★★★★★★#8410 · hits 67% · avg +1.7% | Raymond James | $350 → $320−8.6% | Buy | +5.9% | Reiterated | 03.08.26on TipRanks 07:31 | −0.3%next day −4.6% · 5 days −3.3% | ↗ |
| Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% | Goldman Sachs | $340 → $352+3.5% | Buy | +16.4% | Reiterated | 02.08.26on TipRanks Aug 3 08:10 | −0.3%next day −4.6% · 5 days −3.3% | ↗ |
| George Hill★★★★★★★★★★#1126 · hits 54% · avg +9.0% | Deutsche Bank | $302 → $305+1.0% | Hold | +0.9% | Reiterated | 31.07.26on TipRanks Aug 6 18:00 | −3.7%next day −0.3% · 5 days −2.3% | ↗ |
| Unknown Analyst | Oppenheimer | $365 | Buy | +20.7% | Reiterated | 31.07.26on TipRanks 08:41 | −3.7%next day −0.3% · 5 days −2.3% | ↗ |
| Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% | Robert W. Baird | $337 → $362+7.4% | Buy | +19.7% | Reiterated | 31.07.26on TipRanks 07:23 | −3.7%next day −0.3% · 5 days −2.3% | ↗ |
| Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% | J.P. Morgan | — | Buy | — | Reiterated | 30.07.26on TipRanks Jul 31 09:55 | −4.6%next day −3.7% · 5 days −7.9% | ↗ |
| Jason Cassorla★★★★★★★★★★#3435 · hits 57% · avg +5.7% | Guggenheim | $338 → $361+6.8% | Buy | +19.4% | Reiterated | 30.07.26on TipRanks Jul 31 07:00 | −4.6%next day −3.7% · 5 days −7.9% | ↗ |
| Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% | Mizuho Securities | $330 → $340+3.0% | Buy | +12.5% | Reiterated | 08.06.26on TipRanks 07:35 | −0.2%next day +2.2% · 5 days −0.7% | ↗ |
| A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% | UBS | $375 → $400+6.7% | Buy | +32.3% | Reiterated | 22.05.26on TipRanks Jun 8 07:35 | +1.1%next day −2.6% · 5 days −5.9% | ↗ |
| Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% | Cantor Fitzgerald | $325 → $340+4.6% | Buy | +12.5% | Reiterated | 30.04.26on TipRanks May 1 08:12 | −1.6%next day −2.9% · 5 days −4.0% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Cigna
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $337 at a price of $272 (+24.1%); now: $339 at $302 (+12.1%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 20 | 18 | 24 | 16 | 20 | 13 |
| Hold | 3 | 3 | 5 | 4 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $7.52 (from $7.42 to $7.80). Last quarter: $7.78.
Sales
Next quarter’s sales estimate — $72.6B (from $70.5B to $74.3B). Last quarter: $71.6B.
Best top-analyst consensus in the sector · Healthcare
About Cigna
- CEO: Brian C. Evanko
- Employees: 66,685
- 900 Cottage Grove Road, Bloomfield, CT, 06002, US
- www.thecignagroup.com
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
Data from the stock’s TipRanks forecast page, read 4 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗